NCT04477226 is a clinical trial of Transvaginal ultrasound scan in Induction of Labour, sponsored by Universiti Kebangsaan Malaysia Medical Centre.

Who is sponsoring NCT04477226?

NCT04477226 is sponsored by Universiti Kebangsaan Malaysia Medical Centre.

What drugs are being tested in NCT04477226?

Interventions in NCT04477226: Transvaginal ultrasound scan.

What condition does NCT04477226 study?

NCT04477226 studies Induction of Labour.

Is NCT04477226 still recruiting?

NCT04477226 is currently completed. Last updated 20 July 2020.

Last reviewed 2020-07-20 · How we verify

NCT04477226

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transvaginal Ultrasound As Predictors of Successful Induction of Labour

Completed Last updated 20 July 2020

What this trial tests

trial testing Transvaginal ultrasound scan in Induction of Labour in 294 participants. Completed in 31 December 2019.

Timeline

1 January 2019

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	Universiti Kebangsaan Malaysia Medical Centre
Status	Completed
Study type	OBSERVATIONAL
Enrollment	294
Start date	1 January 2019
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	1 location across Malaysia

Drugs / interventions tested

Transvaginal ultrasound scan

Conditions studied

Induction of Labour — all drugs for Induction of Labour →

Sponsor

Universiti Kebangsaan Malaysia Medical Centre — full company profile →

Who can join

Adults 18 to 45, female only, with Induction of Labour. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the use of transvaginal ultrasound (TVUS) of cervix to the Bishops score prior to induction of labour in term pregnancies, and the ability to predict Caesarean delivery for failure to progress.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Universiti Kebangsaan Malaysia Medical Centre trials

Trials by the same sponsor.

NCT07466485 — The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFL · Phase 2 · recruiting
NCT07041814 — A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRI · Phase 2 · not yet recruiting
NCT07000227 — Mechanism of FODMAP Restriction on FGID Patients · NA · recruiting
NCT05694858 — Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adu · Phase 1, PHASE2 · recruiting
NCT07447310 — Comparing 360-degree VR Video of Local vs Overseas Environment on Psychological Health · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04477226 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universiti Kebangsaan Malaysia Medical Centre
Last refreshed: 20 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04477226.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing